MedPath

CONNECTing Head and Neck Caregivers to Supportive Care Resources

Not Applicable
Completed
Conditions
Head and Neck Cancer
Interventions
Behavioral: CONNECT
Behavioral: CONTROL
Registration Number
NCT03875885
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The purpose of this research is to determine feasibility and acceptability of randomized pilot trial to evaluate a technology-based intervention (CONNECT) to empower and educate caregivers about the benefits of supportive care resources, identify their unmet needs, and connect them with resources.

Detailed Description

The registration is for Objective two and three that refers to the clinical trial. The investigators will determine their ability to recruit caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center to a study that uses a technology-based intervention, CONNECT, which may increase head and neck cancer caregivers' knowledge about the benefits of supportive care resources, identify their unmet needs, and connect them with supportive care resources. In this study the investigators also want to look at their ability to recruit a control group of caregivers, that is, caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center that will receive a list of supportive care resources. Control groups are used in research to see if the intervention being studied really does have an effect. In addition, the investigators will determine whether or not the intervention has led to improvements in caregivers' use of supportive care resources, quality of care, and overall quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Eligible caregivers include those who are:

  • Caregivers must be providing some capacity of informal (unpaid) care for a patient meeting patient eligibility criteria. If a patient unexpectedly becomes deceased during the study period, caregivers will be allowed to continue participation in the assigned study arm and complete study assessments if they wish to.
  • Greater than or equal to 18 years of age.
  • Ability to access study materials by internet or complete study activities in person as institutional and government policies allow.

Eligible patients include those who:

  • Have new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV head and neck cancer.
  • Are receiving cancer treatment or awaiting planned treatment initiation, excluding those receiving neoadjuvant surgery or surgery only.
  • Patients must be ambulatory and up more than 50% of waking hours, as measured by an ECOG Performance Status rating of level 0, 1, or 2.
  • Greater than or equal to 18 years of age.
  • Ability to access study materials by internet or complete study activities in person as institutional and government policies allow.
  • Patients must be receiving some capacity of informal care from a caregiver meeting the above criteria. If the caregiver unexpectedly becomes deceased during the study period, the patient will be un-enrolled from this study as we are evaluating a caregiver-only delivered intervention.
Read More
Exclusion Criteria

Caregivers will be excluded if:

• Cannot read/communicate in English

Patients will be excluded if they:

• Cannot read/communicate in English

Eligibility to participate in the study is conditional on participation of both the caregiver and patient.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CONNECT Intervention Group - Group ACONNECTA web-based intervention (CONNECT) to empower and connect caregivers of newly diagnosed cancer patients to supportive care resources A randomized pilot study will be conducted to assess feasibility and acceptability and obtain data on caregiver and patient outcomes. CONNECT e-tool, re-education and optional referral (2 weeks post CONNECT e-tool). Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
CONNECT Comparison Group - Group BCONTROLBaseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
Primary Outcome Measures
NameTimeMethod
Proportion of Caregivers Who Agree to Participate19 months

Number of caregivers who agreed to participate divided by the number of months of recruitment

Number of Retention of Participants9 months

Number of participants who completed the T2 assessment divided by the number who agreed to participate

Acceptability - (Intervention Arm Only)9 months

Survey developed for study to assess how much caregivers liked different aspects of CONNECT; and a \~30min (approximately) qualitative interview to further explore acceptability (measures were strongly agree, agree and undecided).

Number of Eligible Participants9 months

Number of eligible participants who agreed to participate

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wake Forest Baptist Comprehensive Cancer Center

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath